Patents A Key Focus As Drug-Pricing Debate Intensifies

October 02, 2020

Intellectual Property special counsel Danielle Tully shares her insights on lawmakers’ interest in how pharmaceutical patents impact drug prices, and comments on the potential benefits of one legislative proposal.   

Read the article here.

CadwaladerNews

To assist individuals in working from home during the coronavirus social-distancing period, Cadwalader is providing clients and friends free access to our legal research platform, the Cadwalader Cabinet.